Merck KGaA (OTCMKTS:MKGAF) Stock Price Up 5% – Here’s Why

Merck KGaA (OTCMKTS:MKGAF)’s stock price shot up 5% during mid-day trading on Wednesday . The company traded as high as $130.2280 and last traded at $130.2280. 242 shares changed hands during mid-day trading, a decline of 59% from the average session volume of 596 shares. The stock had previously closed at $124.00.

Merck KGaA Trading Down 0.2%

The firm has a market cap of $16.84 billion, a PE ratio of 19.89 and a beta of 0.96. The company has a 50-day simple moving average of $147.34 and a 200 day simple moving average of $139.78. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27.

Merck KGaA Company Profile

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.